目录肽产品
MART-002A
MART-1 (27-35) (human)
H-Ala-Ala-Gly-Ile-Gly-Ile-Leu-Thr-Val-OH\nAcetate salt
H-Ala-Ala-Gly-Ile-Gly-Ile-Leu-Thr-Val-OH\nAcetate salt
Size：1
P1(RMB)：254
MW：813.99
One letter sequence：AAGIGILTV
Molecular Formula：C37H67N9O11
Description：Melan A corresponds to residues 27-35 of the nonmutated melanoma-associated antigen MART-1/Melan A. The sequence AAGIGILTV is the immunodominant epitope recognized by most melanoma-specific, HLA-A*0201-restricted, cytotoxic T lymphocytes (CTL).
Literature Reference：A.van Elsas et al., Eur. J. Immunol., 26, 1683 (1996)\nM.J.M?urer et al., Eur. J. Immunol., 26, 2613 (1996)\nJ.N.Cormier et al., Cancer J. Sci. Am., 3, 37 (1997)\nF.O.Nestle et al., Nat. Med., 4, 328 (1998)\nM.P.Velders et al., Crit. Rev. Immunol., 18, 7 (1998)
Cas：156251-11-5
P1(RMB)：254
MW：813.99
One letter sequence：AAGIGILTV
Molecular Formula：C37H67N9O11
Description：Melan A corresponds to residues 27-35 of the nonmutated melanoma-associated antigen MART-1/Melan A. The sequence AAGIGILTV is the immunodominant epitope recognized by most melanoma-specific, HLA-A*0201-restricted, cytotoxic T lymphocytes (CTL).
Literature Reference：A.van Elsas et al., Eur. J. Immunol., 26, 1683 (1996)\nM.J.M?urer et al., Eur. J. Immunol., 26, 2613 (1996)\nJ.N.Cormier et al., Cancer J. Sci. Am., 3, 37 (1997)\nF.O.Nestle et al., Nat. Med., 4, 328 (1998)\nM.P.Velders et al., Crit. Rev. Immunol., 18, 7 (1998)
Cas：156251-11-5
